首页 > 最新文献

Praxis最新文献

英文 中文
[Liver Cirrhosis]. [肝硬化]。
Q4 Medicine Pub Date : 2023-09-01
Robert Brenig, Christine Bernsmeier

Introduction: Cirrhosis is a common disease with high morbidity and mortality. In industrialised countries, the most common causes of cirrhosis are the alcoholic liver disease, non-alcoholic fatty liver disease and chronic viral hepatitis. Cirrhosis is often diagnosed late, as it can be asymptomatic for a long time. Therefore, hepatopathy screening in high-risk patients and fibrosis surveillance using the ultrasound, in the presence of a chronic hepatopathy are essential. A liver biopsy is necessary to confirm the diagnosis. With optimal therapy, in some cases, cirrhosis is preventable and potentially reversible in others. In the stage of decompensation, typically characterised by ascites, patients often die from recurrent infections or hepatocellular carcinoma unless cured by liver transplantation. The prevention and treatment of complications as well as the evaluation of a transplant require cooperation with a centre hospital.

导语:肝硬化是一种常见病,发病率高,死亡率高。在工业化国家,肝硬化最常见的原因是酒精性肝病、非酒精性脂肪性肝病和慢性病毒性肝炎。肝硬化通常诊断较晚,因为它可能长期无症状。因此,在存在慢性肝病的情况下,对高危患者进行肝病筛查和使用超声监测纤维化是至关重要的。肝活检是必要的,以确认诊断。在某些情况下,通过最佳治疗,肝硬化是可以预防的,在其他情况下可能是可逆的。在以腹水为特征的失代偿期,除非通过肝移植治愈,否则患者通常死于复发性感染或肝细胞癌。并发症的预防和治疗以及移植的评估需要与中心医院合作。
{"title":"[Liver Cirrhosis].","authors":"Robert Brenig,&nbsp;Christine Bernsmeier","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Cirrhosis is a common disease with high morbidity and mortality. In industrialised countries, the most common causes of cirrhosis are the alcoholic liver disease, non-alcoholic fatty liver disease and chronic viral hepatitis. Cirrhosis is often diagnosed late, as it can be asymptomatic for a long time. Therefore, hepatopathy screening in high-risk patients and fibrosis surveillance using the ultrasound, in the presence of a chronic hepatopathy are essential. A liver biopsy is necessary to confirm the diagnosis. With optimal therapy, in some cases, cirrhosis is preventable and potentially reversible in others. In the stage of decompensation, typically characterised by ascites, patients often die from recurrent infections or hepatocellular carcinoma unless cured by liver transplantation. The prevention and treatment of complications as well as the evaluation of a transplant require cooperation with a centre hospital.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"112 11","pages":"554-561"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41210470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Post-COVID Rehabilitation]. [新冠肺炎康复]。
Q4 Medicine Pub Date : 2023-09-01
Jutta Küst, Andreas Disko, Luigi Riccardo Calendo, Bartosz Bujan

Introduction: COVID-19 is a multi-organ disease with a broad spectrum of manifestations. Many affected individuals have major difficulties in resuming their previous daily routine or occupation as a result of the disease. Currently, no causal therapeutic approaches are available for the treatment of post-COVID disease. Due to the wide range of possible symptoms, an interprofessional and integrated treatment should be used, while rehabilitation and interventions should be based on the objective findings as well as on the patient's goals. Fatigue and cognitive impairment are among the most common symptoms, which can limit both occupational participation and coping with everyday life. Fatigue management is a central component of rehabilitation. The workload should be increased very slowly; indications of post-exertional malaise must be given special consideration. Due to the fluctuating course of the disease, a periodic reevaluation and adjustment of the workload may be necessary.

简介:新冠肺炎是一种多器官疾病,表现广泛。由于这种疾病,许多受影响的人在恢复以前的日常生活或职业方面遇到了重大困难。目前,没有因果治疗方法可用于治疗新冠肺炎后疾病。由于可能出现的症状范围广泛,应采用跨专业综合治疗,而康复和干预措施应基于客观发现和患者的目标。疲劳和认知障碍是最常见的症状之一,它们会限制职业参与和应对日常生活。疲劳管理是康复的核心组成部分。工作量的增加应该非常缓慢;必须特别考虑运动后不适的迹象。由于病程的波动性,可能需要定期重新评估和调整工作量。
{"title":"[Post-COVID Rehabilitation].","authors":"Jutta Küst,&nbsp;Andreas Disko,&nbsp;Luigi Riccardo Calendo,&nbsp;Bartosz Bujan","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>COVID-19 is a multi-organ disease with a broad spectrum of manifestations. Many affected individuals have major difficulties in resuming their previous daily routine or occupation as a result of the disease. Currently, no causal therapeutic approaches are available for the treatment of post-COVID disease. Due to the wide range of possible symptoms, an interprofessional and integrated treatment should be used, while rehabilitation and interventions should be based on the objective findings as well as on the patient's goals. Fatigue and cognitive impairment are among the most common symptoms, which can limit both occupational participation and coping with everyday life. Fatigue management is a central component of rehabilitation. The workload should be increased very slowly; indications of post-exertional malaise must be given special consideration. Due to the fluctuating course of the disease, a periodic reevaluation and adjustment of the workload may be necessary.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"112 11","pages":"566-570"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41210472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Revascularisation of Asymptomatic Carotid Stenosis - Reasonable or Obsolete?] [无症状颈动脉狭窄的再治疗-合理还是过时?]
Q4 Medicine Pub Date : 2023-09-01
Benedikt Reutersberg, Thomas Stadlbauer, Philip Düppers, Lorenz Meuli, Alexander Zimmermann

Introduction: Recommendations for surgical versus conservative treatment of asymptomatic carotid stenosis (ACS) are based on prospective randomized trials, some of which were performed several decades ago. However, during this time, "best medical treatment" (BMT) for conservative therapy of arteriosclerotic patients has evolved significantly. Because of the associated risk reduction of ACS, surgical therapy is increasingly being questioned. By identifying clinical and morphological risk parameters, subgroups could be identified that might, however, benefit from invasive therapy. Consequently, multidisciplinary therapy decision-making requires an increasingly patient-individualized approach.

引言:手术治疗与保守治疗无症状颈动脉狭窄(ACS)的建议基于前瞻性随机试验,其中一些试验是几十年前进行的。然而,在这段时间里,动脉硬化患者保守治疗的“最佳药物治疗”(BMT)有了显著的发展。由于ACS的相关风险降低,外科治疗越来越受到质疑。通过确定临床和形态学风险参数,可以确定可能受益于侵入性治疗的亚组。因此,多学科治疗决策需要越来越多的患者个性化方法。
{"title":"[Revascularisation of Asymptomatic Carotid Stenosis - Reasonable or Obsolete?]","authors":"Benedikt Reutersberg,&nbsp;Thomas Stadlbauer,&nbsp;Philip Düppers,&nbsp;Lorenz Meuli,&nbsp;Alexander Zimmermann","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Recommendations for surgical versus conservative treatment of asymptomatic carotid stenosis (ACS) are based on prospective randomized trials, some of which were performed several decades ago. However, during this time, \"best medical treatment\" (BMT) for conservative therapy of arteriosclerotic patients has evolved significantly. Because of the associated risk reduction of ACS, surgical therapy is increasingly being questioned. By identifying clinical and morphological risk parameters, subgroups could be identified that might, however, benefit from invasive therapy. Consequently, multidisciplinary therapy decision-making requires an increasingly patient-individualized approach.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"112 11","pages":"545-553"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41210473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Surgery, Antibiotic Treatment or Both?] [手术、抗生素治疗还是两者兼而有之?]
Q4 Medicine Pub Date : 2023-09-01
Meret Joanna Zehnder, Alexia Cusini

Introduction: The 90-year-old female patient with underlying rheumatoid arthritis and spinal canal stenosis was admitted to hospital for pain control. The clinical exam of the lower abdomen was impressively painful and the inflammatory parameters were significantly increased. For further diagnosis a computer tomography was performed, showing a covered perforated appendicitis with a perityphlitic abscess. The conservative therapy with abscess drainage and antibiotics was successful.

引言:一位90岁的女性患者因潜在的类风湿性关节炎和椎管狭窄入院接受疼痛控制。下腹部的临床检查令人印象深刻地疼痛,炎症参数显著增加。为了进一步诊断,进行了计算机断层扫描,显示有盖的穿孔阑尾炎和腹膜周围脓肿。脓肿引流和抗生素的保守治疗是成功的。
{"title":"[Surgery, Antibiotic Treatment or Both?]","authors":"Meret Joanna Zehnder,&nbsp;Alexia Cusini","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>The 90-year-old female patient with underlying rheumatoid arthritis and spinal canal stenosis was admitted to hospital for pain control. The clinical exam of the lower abdomen was impressively painful and the inflammatory parameters were significantly increased. For further diagnosis a computer tomography was performed, showing a covered perforated appendicitis with a perityphlitic abscess. The conservative therapy with abscess drainage and antibiotics was successful.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"112 11","pages":"578-580"},"PeriodicalIF":0.0,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41210474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[When the Brain Stops the Heart]. [当大脑停止心跳]。
Q4 Medicine Pub Date : 2023-08-01
Urs Fisch

Introduction:

简介:
{"title":"[When the Brain Stops the Heart].","authors":"Urs Fisch","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong></p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"112 10","pages":"530"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49681527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Conspicuous Conditions of the Tongue: Normal Variants vs. Pathological Findings]. [舌的明显情况:正常变异与病理结果]。
Q4 Medicine Pub Date : 2023-08-01
Martina Broglie Däppen, Günter Toman Müller, Thomas Gander

Introduction: With its sensitivity, taste buds and complex anatomical structure of various muscles, the tongue is a central organ for speaking, tasting and food intake, especially oral food transport, chewing and swallowing. Changes in the tongue 's condition are frequent and often lead to uncertainty among patients and eventually to a visit to the family doctor, to the ear, nose and throat specialist, dentist or maxillofacial surgeon. The question whether the condition of the tongue is a lesion requiring treatment or just a variant can quite often prove a major challenge. The differential diagnoses are wide-ranging from harmless changes to alarming signs of disease. The time and duration of occurrence, the accompanying symptoms such as a burning sensation or taste disorders as well as risk factors such as nicotine and alcohol consumption are important anamnestic elements. Possible causes can be malnutrition, systemic diseases, inflammatory processes or malignancies. Accordingly, a blood test and a smear or a biopsy may be necessary as the first diagnostic step. The aim of this review is to explain the different types and causes of tongue problems and to explain in which cases further clarifications are necessary.

引言:舌头具有敏感性、味蕾和各种肌肉的复杂解剖结构,是说话、品尝和进食的中心器官,尤其是口腔食物运输、咀嚼和吞咽。舌头状况的变化是频繁的,通常会导致患者的不确定性,最终会去看家庭医生、耳鼻喉专家、牙医或颌面外科医生。舌头的状况是需要治疗的病变,还是只是一种变体,这往往是一个重大挑战。鉴别诊断范围很广,从无害的变化到令人担忧的疾病迹象。发生的时间和持续时间,伴随的症状,如灼烧感或味觉障碍,以及风险因素,如尼古丁和饮酒,都是重要的记忆因素。可能的原因可能是营养不良、系统性疾病、炎症过程或恶性肿瘤。因此,血液测试和涂片或活检可能是必要的第一诊断步骤。这篇综述的目的是解释舌头问题的不同类型和原因,并解释在哪些情况下需要进一步澄清。
{"title":"[Conspicuous Conditions of the Tongue: Normal Variants vs. Pathological Findings].","authors":"Martina Broglie Däppen,&nbsp;Günter Toman Müller,&nbsp;Thomas Gander","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>With its sensitivity, taste buds and complex anatomical structure of various muscles, the tongue is a central organ for speaking, tasting and food intake, especially oral food transport, chewing and swallowing. Changes in the tongue 's condition are frequent and often lead to uncertainty among patients and eventually to a visit to the family doctor, to the ear, nose and throat specialist, dentist or maxillofacial surgeon. The question whether the condition of the tongue is a lesion requiring treatment or just a variant can quite often prove a major challenge. The differential diagnoses are wide-ranging from harmless changes to alarming signs of disease. The time and duration of occurrence, the accompanying symptoms such as a burning sensation or taste disorders as well as risk factors such as nicotine and alcohol consumption are important anamnestic elements. Possible causes can be malnutrition, systemic diseases, inflammatory processes or malignancies. Accordingly, a blood test and a smear or a biopsy may be necessary as the first diagnostic step. The aim of this review is to explain the different types and causes of tongue problems and to explain in which cases further clarifications are necessary.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"112 10","pages":"524-529"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49681523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Chlorthalidone or hydrochlorothiazide as the first choice in the treatment of people with hypertension]. [首选氯噻酮或氢氯噻嗪治疗高血压患者]。
Q4 Medicine Pub Date : 2023-08-01
Johann Steurer

Introduction:

简介:
{"title":"[Chlorthalidone or hydrochlorothiazide as the first choice in the treatment of people with hypertension].","authors":"Johann Steurer","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong></p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"112 10","pages":"493"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49681522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[«Diabetes Drugs» without Diabetes: SGLT-2 Inhibitors]. [不含糖尿病的«糖尿病药物»:SGLT-2抑制剂]。
Q4 Medicine Pub Date : 2023-08-01
Danaë Parianos, Matthias Hermann

Introduction: No other class of drugs has caused as much of a stir in the last decade as sodium-glucose linked transporter 2 inhibitors (SGLT-2i) or gliflozines. At the latest since the SGLT-2i originally developed as a diabetes mellitus drug unexpectedly also showed protective effects for heart and kidney in pivotal studies, they are now the talk of the town. Although the cellular and molecular mechanisms have not yet been clarified in all details, they have revolutionized therapeutic approaches for diabetes mellitus, heart failure independent of left ventricular ejection fraction, and nephropathies based on positive data available. The purpose of this article is to review the effects and postulated mechanisms of action of SGLT-2 inhibitors, particularly in heart failure and renal failure, and to outline their potential risks and side effects.

引言:在过去的十年里,没有其他类别的药物能像钠-葡萄糖连接转运蛋白2抑制剂(SGLT-2i)或格列吡嗪那样引起如此大的轰动。最近,由于最初作为糖尿病药物开发的SGLT-2i在关键研究中出人意料地也显示出对心脏和肾脏的保护作用,它们现在成了人们谈论的话题。尽管细胞和分子机制尚未完全阐明,但它们已经彻底改变了糖尿病、不依赖于左心室射血分数的心力衰竭和基于现有积极数据的肾病的治疗方法。本文的目的是综述SGLT-2抑制剂的作用和假定的作用机制,特别是在心力衰竭和肾衰竭中,并概述其潜在的风险和副作用。
{"title":"[«Diabetes Drugs» without Diabetes: SGLT-2 Inhibitors].","authors":"Danaë Parianos,&nbsp;Matthias Hermann","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>No other class of drugs has caused as much of a stir in the last decade as sodium-glucose linked transporter 2 inhibitors (SGLT-2i) or gliflozines. At the latest since the SGLT-2i originally developed as a diabetes mellitus drug unexpectedly also showed protective effects for heart and kidney in pivotal studies, they are now the talk of the town. Although the cellular and molecular mechanisms have not yet been clarified in all details, they have revolutionized therapeutic approaches for diabetes mellitus, heart failure independent of left ventricular ejection fraction, and nephropathies based on positive data available. The purpose of this article is to review the effects and postulated mechanisms of action of SGLT-2 inhibitors, particularly in heart failure and renal failure, and to outline their potential risks and side effects.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"112 10","pages":"500-506"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49681521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Why Switzerland needs evidence-based guidelines for its general practice medicine]. 【为什么瑞士需要全科医学循证指南】。
Q4 Medicine Pub Date : 2023-08-01
Andrea Rosemann, Oliver Senn, Stefan Neuner-Jehle, Stefan Markun, Thomas Rosemann

Introduction: Medical guidelines summarize evidence based knowledge and give helpful recommendations for diagnostics and therapy in daily practice. Most Swiss medical societies therefore adapt international guidelines for the Swiss setting. In primary care this adaption must not only take into account the specific Swiss healthcare system, but also the specific setting of primary care, which is characterized by a low prevalence of most diseases as well as by chronic conditions and multimorbidity. Exactly these multimorbid patients are underrepresented in the studies, which underline the current guidelines of medical societies. The institute of primary care at the university of Zurich, IHAMZ, therefore creates evidence based guidelines according to international established quality criteria for the Swiss primary care setting.

引言:医学指南总结了基于证据的知识,并为日常实践中的诊断和治疗提供了有用的建议。因此,大多数瑞士医学会根据瑞士的情况调整国际指南。在初级保健中,这种适应不仅必须考虑到瑞士特定的医疗保健系统,还必须考虑到初级保健的特定环境,其特点是大多数疾病的发病率低,以及慢性病和多发病。确切地说,这些多发病患者在研究中的代表性不足,这突出了医学会目前的指导方针。因此,苏黎世大学初级保健研究所IHAMZ根据瑞士初级保健环境的国际既定质量标准制定了基于证据的指导方针。
{"title":"[Why Switzerland needs evidence-based guidelines for its general practice medicine].","authors":"Andrea Rosemann,&nbsp;Oliver Senn,&nbsp;Stefan Neuner-Jehle,&nbsp;Stefan Markun,&nbsp;Thomas Rosemann","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Medical guidelines summarize evidence based knowledge and give helpful recommendations for diagnostics and therapy in daily practice. Most Swiss medical societies therefore adapt international guidelines for the Swiss setting. In primary care this adaption must not only take into account the specific Swiss healthcare system, but also the specific setting of primary care, which is characterized by a low prevalence of most diseases as well as by chronic conditions and multimorbidity. Exactly these multimorbid patients are underrepresented in the studies, which underline the current guidelines of medical societies. The institute of primary care at the university of Zurich, IHAMZ, therefore creates evidence based guidelines according to international established quality criteria for the Swiss primary care setting.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"112 10","pages":"488-491"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49681528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Symptom Control in Nephrological Palliative Care]. [肾病姑息治疗中的症状控制]。
Q4 Medicine Pub Date : 2023-08-01
Stefan Pelz, Elena Rho, Fanny Wolfensberger, David Blum

Introduction: Nephrology may have quite a lot in common with with palliative care. Examples of this are the conservative therapy of a terminal chronic kidney disease or dialysis termination. Nevertheless, palliative co-care of patients with chronic kidney disease still happens rather rarely. On the one hand, this might be due to lacking experience regarding the benefits and opportunities of incorporating palliative care in nephrology care, on the other hand, palliative care is often misunderstood as pure "end-of-life" care. By highlighting the whole spectrum of palliative care, we aim to promote these two disciplines in order to integrate palliative care services into the nephrological treatment concept at an early stage.

引言:肾病学可能与姑息治疗有很多共同点。这方面的例子是晚期慢性肾脏疾病的保守治疗或透析终止。然而,慢性肾脏病患者的姑息性联合治疗仍然很少发生。一方面,这可能是由于缺乏将姑息治疗纳入肾脏病护理的益处和机会方面的经验,另一方面,姑息治疗经常被误解为纯粹的“临终”护理。通过强调姑息治疗的全方位,我们旨在推广这两个学科,以便在早期将姑息治疗服务纳入肾脏病治疗理念。
{"title":"[Symptom Control in Nephrological Palliative Care].","authors":"Stefan Pelz,&nbsp;Elena Rho,&nbsp;Fanny Wolfensberger,&nbsp;David Blum","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Introduction: </strong>Nephrology may have quite a lot in common with with palliative care. Examples of this are the conservative therapy of a terminal chronic kidney disease or dialysis termination. Nevertheless, palliative co-care of patients with chronic kidney disease still happens rather rarely. On the one hand, this might be due to lacking experience regarding the benefits and opportunities of incorporating palliative care in nephrology care, on the other hand, palliative care is often misunderstood as pure \"end-of-life\" care. By highlighting the whole spectrum of palliative care, we aim to promote these two disciplines in order to integrate palliative care services into the nephrological treatment concept at an early stage.</p>","PeriodicalId":20494,"journal":{"name":"Praxis","volume":"112 10","pages":"516-523"},"PeriodicalIF":0.0,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49681525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Praxis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1